T. Lucas - 28 Nov 2025 Form 4 Insider Report for Envoy Medical, Inc. (COCH)

Role
Chief Executive Officer, Director
Signature
s/ Andrew Nick as Attorney-in-Fact for Brent Lucas pursuant to Power of Attorney previously filed.
Issuer symbol
COCH
Transactions as of
28 Nov 2025
Transactions value $
$12,909
Form type
4
Filing time
10 Dec 2025, 17:49:36 UTC
Previous filing
13 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lucas Brent T. Chief Executive Officer, Director C/O 4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE s/ Andrew Nick as Attorney-in-Fact for Brent Lucas pursuant to Power of Attorney previously filed. 10 Dec 2025 0001994382

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COCH Class A Common Stock Award $12.9K +18.1K +8.36% $0.71 235K 28 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding COCH Stock Option (right to buy) 880K 28 Nov 2025 Class A Common Stock 880K $2.40 Direct F2
holding COCH Warrant (right to buy) 94.3K 28 Nov 2025 Class A Common Stock 94.3K $11.50 Direct F3
holding COCH Warrant (right to buy) 111K 28 Nov 2025 Class A Common Stock 16.7K $11.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Envoy Medical, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 Options to purchase 659,811 shares vest on 10/15/2023, and 219,938 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.
F3 Fully exercisable.